{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03936049","recordId":"NCT03936049","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03936049-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03936049.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03936049.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-30","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"7b886026f72e5f1d2e93a534da097a26960fd84456d27a8a2f0efaed4da69f04","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Document Section","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-06-24","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"5bd0e6d3f3e94e87ec1ec69b6c1805bcd322432b5520cd01ad73470573514b65","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Arms and Interventions","Document Section","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-12-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-12-30","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"dbb0e8b12b974644f1bf5167dd2f6d9e9cc8e09447eb29ea73bedcc8179622bf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Document Section","Eligibility","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2023-07-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2023-07-25","publishedAt":"2026-08-23","recordId":"NCT03936049","recordSha256":"070c642b7757eceae37e79a1e7fee250c8b21f629cd74deea730d0df0ce134b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03936049?a=4&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"6e24338a8d89183dcec1f4b0a340ab493efed4b5472d268f125315215351fc20"}}